These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 26196942)

  • 1. Diagnostic and Prognostic Values of Noninvasive Predictors of Portal Hypertension in Patients with Alcoholic Cirrhosis.
    Cho EJ; Kim MY; Lee JH; Lee IY; Lim YL; Choi DH; Kim YJ; Yoon JH; Baik SK
    PLoS One; 2015; 10(7):e0133935. PubMed ID: 26196942
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elastography, spleen size, and platelet count identify portal hypertension in patients with compensated cirrhosis.
    Berzigotti A; Seijo S; Arena U; Abraldes JG; Vizzutti F; García-Pagán JC; Pinzani M; Bosch J
    Gastroenterology; 2013 Jan; 144(1):102-111.e1. PubMed ID: 23058320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic efficacy of noninvasive liver fibrosis indexes in predicting portal hypertension in patients with cirrhosis.
    Wang L; Feng Y; Ma X; Wang G; Wu H; Xie X; Zhang C; Zhu Q
    PLoS One; 2017; 12(8):e0182969. PubMed ID: 28820885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of early portal hypertension with routine data and liver stiffness in patients with asymptomatic liver disease: a prospective study.
    Augustin S; Millán L; González A; Martell M; Gelabert A; Segarra A; Serres X; Esteban R; Genescà J
    J Hepatol; 2014 Mar; 60(3):561-9. PubMed ID: 24211744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measurement of spleen stiffness to evaluate portal hypertension and the presence of esophageal varices in patients with HCV-related cirrhosis.
    Colecchia A; Montrone L; Scaioli E; Bacchi-Reggiani ML; Colli A; Casazza G; Schiumerini R; Turco L; Di Biase AR; Mazzella G; Marzi L; Arena U; Pinzani M; Festi D
    Gastroenterology; 2012 Sep; 143(3):646-654. PubMed ID: 22643348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. von Willebrand factor as new noninvasive predictor of portal hypertension, decompensation and mortality in patients with liver cirrhosis.
    Ferlitsch M; Reiberger T; Hoke M; Salzl P; Schwengerer B; Ulbrich G; Payer BA; Trauner M; Peck-Radosavljevic M; Ferlitsch A
    Hepatology; 2012 Oct; 56(4):1439-47. PubMed ID: 22532296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pro-C5, a marker of true type V collagen formation and fibrillation, correlates with portal hypertension in patients with alcoholic cirrhosis.
    Leeming DJ; Veidal SS; Karsdal MA; Nielsen MJ; Trebicka J; Busk T; Bendtsen F; Krag A; Møller S
    Scand J Gastroenterol; 2015 May; 50(5):584-92. PubMed ID: 25639675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Can transient elastography, Fib-4, Forns Index, and Lok Score predict esophageal varices in HCV-related cirrhotic patients?
    Hassan EM; Omran DA; El Beshlawey ML; Abdo M; El Askary A
    Gastroenterol Hepatol; 2014 Feb; 37(2):58-65. PubMed ID: 24365388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liver stiffness and the prediction of clinically significant portal hypertension and portal hypertensive complications.
    Kitson MT; Roberts SK; Colman JC; Paul E; Button P; Kemp W
    Scand J Gastroenterol; 2015 Apr; 50(4):462-9. PubMed ID: 25623641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-invasive aspartate aminotransferase to platelet ratio index correlates well with invasive hepatic venous pressure gradient in cirrhosis.
    Kirnake V; Arora A; Sharma P; Goyal M; Chawlani R; Toshniwal J; Kumar A
    Indian J Gastroenterol; 2018 Jul; 37(4):335-341. PubMed ID: 30178093
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum tests, liver stiffness and artificial neural networks for diagnosing cirrhosis and portal hypertension.
    Procopet B; Cristea VM; Robic MA; Grigorescu M; Agachi PS; Metivier S; Peron JM; Selves J; Stefanescu H; Berzigotti A; Vinel JP; Bureau C
    Dig Liver Dis; 2015 May; 47(5):411-6. PubMed ID: 25732434
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transient elastography using Fibroscan is the most reliable noninvasive method for the diagnosis of advanced fibrosis and cirrhosis in alcoholic liver disease.
    Fernandez M; Trépo E; Degré D; Gustot T; Verset L; Demetter P; Devière J; Adler M; Moreno C
    Eur J Gastroenterol Hepatol; 2015 Sep; 27(9):1074-9. PubMed ID: 26011235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatic venous pressure gradient predicts clinical decompensation in patients with compensated cirrhosis.
    Ripoll C; Groszmann R; Garcia-Tsao G; Grace N; Burroughs A; Planas R; Escorsell A; Garcia-Pagan JC; Makuch R; Patch D; Matloff DS; Bosch J;
    Gastroenterology; 2007 Aug; 133(2):481-8. PubMed ID: 17681169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-invasive ménage à trois for the prediction of high-risk varices: stepwise algorithm using lok score, liver and spleen stiffness.
    Stefanescu H; Radu C; Procopet B; Lupsor-Platon M; Habic A; Tantau M; Grigorescu M
    Liver Int; 2015 Feb; 35(2):317-25. PubMed ID: 25228102
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The VITRO Score (Von Willebrand Factor Antigen/Thrombocyte Ratio) as a New Marker for Clinically Significant Portal Hypertension in Comparison to Other Non-Invasive Parameters of Fibrosis Including ELF Test.
    Hametner S; Ferlitsch A; Ferlitsch M; Etschmaier A; Schöfl R; Ziachehabi A; Maieron A
    PLoS One; 2016; 11(2):e0149230. PubMed ID: 26895398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic performance of non-invasive tests for portal hypertension is comparable to that of hepatic venous pressure gradient.
    Jachs M; Hartl L; Simbrunner B; Semmler G; Balcar L; Hofer BS; Schwarz M; Bauer D; Stättermayer AF; Pinter M; Trauner M; Reiberger T; Mandorfer M
    J Hepatol; 2024 May; 80(5):744-752. PubMed ID: 38218352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The cut-off value of transient elastography to the value of hepatic venous pressure gradient in alcoholic cirrhosis.
    Ryu SR; Yoo JJ; Kang SH; Jeong SW; Kim MY; Cho YK; Chang Y; Kim SG; Jang JY; Kim YS; Baik SK; Kim YJ; Park SY; Baymbajav B
    Clin Mol Hepatol; 2021 Jan; 27(1):197-206. PubMed ID: 33317252
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Noninvasive tools and risk of clinically significant portal hypertension and varices in compensated cirrhosis: The "Anticipate" study.
    Abraldes JG; Bureau C; Stefanescu H; Augustin S; Ney M; Blasco H; Procopet B; Bosch J; Genesca J; Berzigotti A;
    Hepatology; 2016 Dec; 64(6):2173-2184. PubMed ID: 27639071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical Evaluation and Prognosis.
    Hernández-Gea V; Berzigotti A
    Dig Dis; 2015; 33(4):515-23. PubMed ID: 26159268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. von Willebrand factor as a novel noninvasive predictor of portal hypertension and esophageal varices in hepatitis B patients with cirrhosis.
    Wu H; Yan S; Wang G; Cui S; Zhang C; Zhu Q
    Scand J Gastroenterol; 2015; 50(9):1160-9. PubMed ID: 25877661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.